Evaluation of humoral and cellular response to third dose of BNT162b2 mRNA COVID-19 vaccine in patients treated with B-cell depleting therapyB세포 고갈 요법으로 치료받은 환자에서 BNT162b2 mRNA COVID-19 백신 3차 접종에 대한 체액 및 세포 반응 평가Article Published on 2022-07-012022-09-11 Journal: Journal of autoimmunity [Category] MERS, 바이오마커, 유전자 메커니즘, 진단, [키워드] affected anti-CD20 anti-S anti-SARS-CoV-2 antibody Autoimmune disease B-cell BNT162b2 CD-20 CD20 cellular immunity cellular response Cohort COVID-19 COVID-19 vaccination COVID-19 vaccine depleting dose doses drug group healthy control healthy controls humoral humoral and cellular immunity IFN-g IgG IMID Immune-mediated inflammatory disease Immune-mediated inflammatory diseases immunogenic immunogenicity Immunosuppressed immunosuppressed patient immunosuppressed patients Inflammatory diseases interferon mRNA mRNA COVID-19 vaccine mRNA COVID-19 vaccines naïve Neutralization assay neutralization assays neutralization titer neutralization titers Neutralizing antibodies neutralizing antibody no significant difference of BNT162b2 Patient patients treated Quantitative reduced response seroconverted significant difference significantly spike subject therapy These data treated vaccination [DOI] 10.1016/j.jaut.2022.102848 PMC 바로가기 [Article Type] Article
Characteristics of patients with immune-mediated inflammatory diseases hospitalized for SARS-CoV-2 infectionArticle Published on 2022-06-012023-07-06 Journal: Reumatología clinica [Category] COVID19(2023년), [키워드] COVID-19 Enfermedades inflamatorias Inmunomediadas Hospitalización Hospitalization IMID Immune-mediated inflammatory diseases Infección por SARS-CoV-2 SARS-COV-2 infection [DOI] 10.1016/j.reumae.2021.03.005 PMC 바로가기
Humoral and cellular responses to spike of δ SARS-CoV-2 variant in vaccinated patients with immune-mediated inflammatory diseasesArticle Published on 2022-04-222023-07-02 Journal: International Journal of Infectious Diseases [Category] COVID19(2023년), SARS, [키워드] COVID-19 IMID immune response T- cell response Vaccine [DOI] 10.1016/j.ijid.2022.04.027 PMC 바로가기 [Article Type] Article
Attenuated anti-SARS-CoV-2 antibody response to vaccination in patients with rheumatic diseases류마티스 질환 환자에서 백신 접종에 대한 약화된 항-SARS-CoV-2 항체 반응Article Published on 2022-02-012022-09-12 Journal: The Journal of Infection [Category] COVID19(2023년), MERS, SARS, 진단, [키워드] Abstract anti-SARS-CoV-2 antibody COVID-19 IMID methotrexate mRNA vaccine Patient psoriatic arthritis response to vaccination rheumatic disease Rheumatoid rheumatoid arthritis SARS-CoV-2 spondyloarthritis vaccination Viral vector vaccine [DOI] 10.1016/j.jinf.2021.12.006 PMC 바로가기 [Article Type] Article
Evaluation of antibody response to BNT162b2 mRNA COVID-19 vaccine in patients affected by immune-mediated inflammatory diseases up to 5 months after vaccination백신 접종 후 최대 5개월까지 면역 매개 염증성 질환에 걸린 환자에서 BNT162b2 mRNA COVID-19 백신에 대한 항체 반응 평가Original Article Published on 2021-11-052022-09-12 Journal: Clinical and experimental medicine [Category] MERS, SARS, 진단, [키워드] affected age anti-CD20 Antibody Response Autoimmune disease biological drug BNT162b2 BNT162b2 mRNA booster dose control group correlation Corticosteroid COVID-19 COVID-19 vaccine demographic drugs elicited enrolled Factor HCW healthcare worker healthy healthy subject humoral immune response IgG IMID Immune-mediated inflammatory disease immunogenicity immunosuppressants magnitude mRNA mRNA BNT162b2 naïve no significant difference participant Patient proportion reduced reduction SARS-CoV-2 SARS-COV-2 infection SARS-CoV-2 vaccination serum IgG significantly significantly lower statistically significant difference supplementary material the disease treated Treatment trials vaccination were recorded [DOI] 10.1007/s10238-021-00771-3 PMC 바로가기 [Article Type] Original Article
A Brighter Side to Thalidomide: Its Potential Use in Immunological Disordersarticle Published on 2017-04-302024-09-01 Journal: Trends in molecular medicine [Category] 한센병, [키워드] cereblon IMID lenalidomide thalidomide [Article Type] article